Our company is dedicated to developing Software as a Medical Device (SaMD) programs in perinatal care, taking an innovative approach to address societal challenges such as preterm birth and miscarriage.
After applying for a patent on the core technology, we started the first clinical study in 2023 and obtained very promising results as a Proof of Concept (PoC). We are planning to move on to the 2nd clinical study in order to accumulate further evidence and to achieve the fastest possible social implementation.
For more information about our research, please visit the link below.